Pfizer has joined the ranks of companies developing cancer drugs that target both PD-1 and VEGF – one of the hottest drug classes in oncology, via a $6 billion licensing deal with China's 3SBio. The ...
Simply collecting data is not enough. You can fill spreadsheets with data, but it's useless if you can't act on it. Regression is one of the most powerful statistical tools for finding relationships ...
It’s time for our Characters of the Week, and we have some strong entries from Chicago PD to High Potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results